Pharmacogenetic Study of Irinotecan Chemotherapy

Official Title

Pharmacogenetic Study of Irinotecan Chemotherapy


This study is aimed at patients with advanced colorectal cancer receiving first dose of an irinotecan containing regimen.

Trial Description

Develop a model using germline polymophisms in enzymes involved with irinotecan glucuronidation to predict toxicity and tumour response after irinotecan therapy.

Interested in this trial?

Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.


Canadian Cancer Society

These resources are provided in partnership with the Canadian Cancer Society